CClinicalTrials.gg
CompletedNCT05734443Updated Sep 24, 2025Results posted

Effects of Task-Specific Step Training on Reactive Balance

An interventional study of step training and treadmill training in Accidental Fall, sponsored by Virginia Polytechnic Institute and State University. Completed at 1 site in United States. Open to participants aged 65 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-24.

Sponsored by Virginia Polytechnic Institute and State University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Nov 2022, registered Feb 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Non-randomized
Ages
65 Years to 80 Years
Sex
All
01

Study summary

The goal of this clinical trial is to evaluate a novel and pragmatic (i.e., not requiring specialized equipment) task-specific step training regimen that aims to improve reactive balance after tripping. The main questions it aims to answer are:

  • Does this step training regimen improve reactive balance after tripping compared to no training?
  • How well does this step training regimen improve reactive balance compared to treadmill training, which is a more commonly studied reactive balance training regimen that uses a specialized treadmill.

Participants will:

  • complete step training or treadmill training (or no training if assigned to the control group) twice a week for three weeks
  • experience a laboratory-induced trip three weeks later to evaluate their reactive balance
02

Conditions studied

  • Accidental Fall
03

In context

Lead sponsor

Virginia Polytechnic Institute and State University is the lead sponsor of 124 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 65-80 years old
  • willing to use wearable sensors for 2-3 weeks (for a separate study)
  • no lower limb amputation
  • not weigh over 250 pounds
  • pass a telephone interview related to cognitive status

Exclusion criteria

Exclusion Criteria:

  • participants must pass a health screening involving a questionnaire that will be reviewed by a health care specialist.
  • participants must not have clinical osteoporosis as indicated by a bone mineral density of the lumbar vertebra and proximal femur of t\<-2.0 as obtained from dual energy x-ray absorptiometry (DEXA), or a DEXA scan completed within the last year.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    step training

    Two training sessions per week will be completed for three consecutive weeks. Each training session will last 0.5-1 hour with an active training time of 30 minutes per participant. Training will involve repeated volitional and reactive stepping movements that mimic the movements necessary to recover balance after tripping while walking.

    Behavioral: step training

  • Experimental
    treadmill training

    Two training sessions per week will be completed for three consecutive weeks. Each training session will last 0.5-1 hour with an active training time of 30 minutes per participant. Training will involve repeated exposure to simulated trips on a treadmill. To simulate a trip, participants first stand on the stationary treadmill belt. A sudden and unexpected increase in backward treadmill belt speed induces a forward loss of balance similar to when tripping. Participants are then required to take steps to recover balance and establish a stable gait pattern before the trial ends. Trials are repeated using pseudo-random speeds that provide variability and are individualized to each participant's capabilities.

    Behavioral: treadmill training

  • No intervention
    Control

Interventions

  • Behavioralstep training

    Participants practice volitional and reactive stepping responses that mimic those needed when recovering balance after tripping.

  • Behavioraltreadmill training

    Sudden treadmill changes in speed (from standing) induce trip-like losses of balance, after which participants take steps to recover balance and establish a stable gait pattern. This is repeated over a range of speeds to both provide training variability and to individualize training to each participant's capability.

06

What researchers measure

Primary outcomes

  1. Trunk Angle at Touchdown of the First Recovery Step

    After a laboratory-induced trip: Angle from vertical of a line connecting midpoint of greater trochanter markers and midpoint of the acromion markers

    Time frame: 1 week after the 3-week intervention

  2. Trip Outcome

    This is a binary variable that has a value of either "fall" or "recovery." After a laboratory-induced trip, trip outcome will be assign to one of the following two values: "fall" if a participant is fully and continuously supported by the harness as observed from video, or if the harness force applied to the participant, integrated over time from trip onset until 1 second after touchdown of the first recovery step, is greater than 40% of body weight \* seconds. The harness force will be measured by a uniaxial load cell. "recovery" if the harness force applied to the participant, integrated over time from trip onset until 1 second after touchdown of the first recovery step, is less than 40% of body weight \* seconds. The harness force will be measured by a uniaxial load cell.

    Time frame: 1 week after the 3-week intervention

Secondary outcomes

  1. Recovery Step Length

    After a laboratory-induced trip, the distance between a lateral malleolus marker of the stance limb and a lateral malleolus marker of the stepping foot at touchdown

    Time frame: 1 week after the 3-week intervention

  2. Sacrum Height at Touchdown of the First Recovery Step

    After a laboratory-induced trip, the minimum distance between the walkway and the greater trochanter marker on the non-tripping limb during trip recovery.

    Time frame: 1 week after the 3-week intervention

  3. Gait Speed

    The average forward speed of the participant prior to the laboratory-induced trip.

    Time frame: 1 week after the 3-week intervention

  4. Average Step Speed

    After a laboratory-induced trip, the distance between a lateral malleolus marker of the stance limb and a lateral malleolus marker of the stepping foot at touchdown divided by the time from impact with the trip obstacle and touchdown of the initial recovery step.

    Time frame: 1 week after the 3-week intervention

  5. Trip Recovery Strategy

    This is a binary variable that has a value of either "elevating" or "lowering." Elevating or lowering, depending upon how the participant uses the foot that trips on the obstacle after the laboratory-induced trip. If the foot is elevated over the obstacle, then this will be elevating. If the foot is lowered to the ground and the opposite foot first steps over the obstacle, then this will be lowering. The measurement tool to determine this outcome is a video recording of the trip, and this outcome has no units.

    Time frame: 1 week after the 3-week intervention

07

Results

Posted Sep 24, 2025

Participant flow

Participant flow — Overall Study
MilestoneStep TrainingTreadmill TrainingControl
Started101010
Completed101010
Not completed000

Outcome measures

PrimaryTrunk Angle at Touchdown of the First Recovery Step

After a laboratory-induced trip: Angle from vertical of a line connecting midpoint of greater trochanter markers and midpoint of the acromion markers

Time frame:
1 week after the 3-week intervention
Reported as:
Mean · degrees
Trunk Angle at Touchdown of the First Recovery Step
degreesStep TrainingTreadmill TrainingControl
Trunk Angle at Touchdown of the First Recovery Step27.0 ± 8.224.6 ± 7.428.4 ± 6.9
PrimaryTrip Outcome

This is a binary variable that has a value of either "fall" or "recovery." After a laboratory-induced trip, trip outcome will be assign to one of the following two values: "fall" if a participant is fully and continuously supported by the harness as observed from video, or if the harness force applied to the participant, integrated over time from trip onset until 1 second after touchdown of the first recovery step, is greater than 40% of body weight \* seconds. The harness force will be measured by a uniaxial load cell. "recovery" if the harness force applied to the participant, integrated over time from trip onset until 1 second after touchdown of the first recovery step, is less than 40% of body weight \* seconds. The harness force will be measured by a uniaxial load cell.

Time frame:
1 week after the 3-week intervention
Reported as:
Number · number of falls
Trip Outcome
number of fallsStep TrainingTreadmill TrainingControl
Trip Outcome4108
SecondaryRecovery Step Length

After a laboratory-induced trip, the distance between a lateral malleolus marker of the stance limb and a lateral malleolus marker of the stepping foot at touchdown

Time frame:
1 week after the 3-week intervention
Reported as:
Mean · % body height
Recovery Step Length
% body heightStep TrainingTreadmill TrainingControl
Recovery Step Length49.5 ± 9.945.4 ± 5.240.1 ± 6.2
SecondarySacrum Height at Touchdown of the First Recovery Step

After a laboratory-induced trip, the minimum distance between the walkway and the greater trochanter marker on the non-tripping limb during trip recovery.

Time frame:
1 week after the 3-week intervention
Reported as:
Mean · % of sacrum height while standing
Sacrum Height at Touchdown of the First Recovery Step
% of sacrum height while standingStep TrainingTreadmill TrainingControl
Sacrum Height at Touchdown of the First Recovery Step97.4 ± 7.396.7 ± 10.197.7 ± 13.0
SecondaryGait Speed

The average forward speed of the participant prior to the laboratory-induced trip.

Time frame:
1 week after the 3-week intervention
Reported as:
Mean · meters per second
Gait Speed
meters per secondStep TrainingTreadmill TrainingControl
Gait Speed1.6 ± 0.21.5 ± 0.21.5 ± 0.2
SecondaryAverage Step Speed

After a laboratory-induced trip, the distance between a lateral malleolus marker of the stance limb and a lateral malleolus marker of the stepping foot at touchdown divided by the time from impact with the trip obstacle and touchdown of the initial recovery step.

Time frame:
1 week after the 3-week intervention
Reported as:
Mean · meters per second
Average Step Speed
meters per secondStep TrainingTreadmill TrainingControl
Average Step Speed1.7 ± 0.41.6 ± 0.21.4 ± 0.3
SecondaryTrip Recovery Strategy

This is a binary variable that has a value of either "elevating" or "lowering." Elevating or lowering, depending upon how the participant uses the foot that trips on the obstacle after the laboratory-induced trip. If the foot is elevated over the obstacle, then this will be elevating. If the foot is lowered to the ground and the opposite foot first steps over the obstacle, then this will be lowering. The measurement tool to determine this outcome is a video recording of the trip, and this outcome has no units.

Time frame:
1 week after the 3-week intervention
Reported as:
Number · number of trips using lowering strategy
Trip Recovery Strategy
number of trips using lowering strategyStep TrainingTreadmill TrainingControl
Trip Recovery Strategy121213

Adverse events

Collected over 1 week after the 3-week intervention. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Step Training0/10 (0%)0/10 (0%)0/10 (0%)
Treadmill Training0/10 (0%)0/10 (0%)0/10 (0%)
Control0/10 (0%)0/10 (0%)0/10 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Step TrainingTreadmill TrainingControlTotal
Mean71.9 ± 4.171.8 ± 5.271.8 ± 4.371.8 ± 4.4
Sex: Female, Male
Sex: Female, Male(Participants)Step TrainingTreadmill TrainingControlTotal
Female66618
Male44412
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Step TrainingTreadmill TrainingControlTotal
Hispanic or Latino0000
Not Hispanic or Latino1091029
Unknown or Not Reported0101
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Step TrainingTreadmill TrainingControlTotal
American Indian or Alaska Native0000
Asian1001
Native Hawaiian or Other Pacific Islander0000
Black or African American0000
White9101029
More than one race0000
Unknown or Not Reported0000
Region of Enrollment
Region of Enrollment(participants)Step TrainingTreadmill TrainingControlTotal
United States10101030
body height
body height(meters)Step TrainingTreadmill TrainingControlTotal
Mean1.63 ± 0.081.69 ± 0.101.70 ± 0.121.68 ± 0.10
body mass
body mass(kilograms)Step TrainingTreadmill TrainingControlTotal
Mean69.9 ± 17.079.6 ± 15.881.9 ± 16.877.1 ± 16.8
unipedal stance time (seconds)
unipedal stance time (seconds)(seconds)Step TrainingTreadmill TrainingControlTotal
Mean18.9 ± 11.516.5 ± 12.717.3 ± 13.817.6 ± 12.3
08

Study locations

1 site
  • Virginia Tech
    Blacksburg, Virginia 24061, United States
09

References and documents

Publications

  • Lee Y, Alexander NB, Franck CT, Castleberry J, Madigan ML. A pilot trial investigating feasibility and preliminary efficacy of a task-specific step training regimen to improve balance recovery among community-dwelling older adults. PLoS One. 2026 Jul 31;21(7):e0354677. doi: 10.1371/journal.pone.0354677. eCollection 2026. PubMed 42536665 ↗

Study documents

  • Protocol and statistical analysis plan · Mar 24, 2025
  • Informed consent form · Mar 24, 2025

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05734443
Lead sponsor
Virginia Polytechnic Institute and State University
Responsible party
Sponsor
First posted
Feb 21, 2023
Start date
Nov 1, 2022
Primary completion
Aug 1, 2023
Completion
Aug 1, 2023
Results posted
Sep 24, 2025
Last update
Sep 24, 2025

Study contacts

Michael L. Madigan, PhD
principal investigator · Virginia Polytechnic Institute and State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion